Background and aims The structured, simplified modified Rankin scale questionnaire (smRSq) may increase reliability over the interrogative approach to scoring the modified Rankin scale (mRS) in acute stroke research and practice. During the conduct of the alteplase-dose arm of the international ENhanced Control of Hypertension ANd Thrombolysis StrokE stuDy (ENCHANTED), we had an opportunity to compare each of these approaches to outcome measurement. Methods Baseline demographic data were recorded together with the National Institutes of Health Stroke Scale (NIHSS). Follow-up measures obtained at 90 days included mRS, smRSq, and the 5-Dimension European Quality of life scale (EQ-5D). Agreements between smRSq and mRS were assessed with the Ka...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose—The diversity of available outcome measures for acute stroke trials is challe...
Background and aims The structured, simplified modified Rankin scale questionnaire (smRSq) may incre...
Background and aims The structured, simplified modified Rankin scale questionnaire (smRSq) may incre...
<br>Background and Purpose—The modified Rankin Scale (mRS) is the recommended functional outco...
Abstract Introduction The modified Rankin Scale (mRS) is used to assess functional outcomes after a ...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and purposeAlthough the modified Rankin Scale (mRS) is the most commonly used primary end...
Abstract Clinical trials are at the centre of advances in our understanding of stroke and its optima...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose-The Barthel Index (BI) and the Modified Rankin Scale (MRS) are commonly used ...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose—The diversity of available outcome measures for acute stroke trials is challe...
Background and aims The structured, simplified modified Rankin scale questionnaire (smRSq) may incre...
Background and aims The structured, simplified modified Rankin scale questionnaire (smRSq) may incre...
<br>Background and Purpose—The modified Rankin Scale (mRS) is the recommended functional outco...
Abstract Introduction The modified Rankin Scale (mRS) is used to assess functional outcomes after a ...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and purposeAlthough the modified Rankin Scale (mRS) is the most commonly used primary end...
Abstract Clinical trials are at the centre of advances in our understanding of stroke and its optima...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose-The Barthel Index (BI) and the Modified Rankin Scale (MRS) are commonly used ...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose—The diversity of available outcome measures for acute stroke trials is challe...